An increase in dementia numbers and global trends in population aging across the world
prompts the need for new medications to treat the complex biological dysfunctions, such as …

Plants remain an important source of new drugs, new drug leads and new chemical entities.
The plant-based drug discovery resulted mainly in the development of anticancer and anti …

Covering: 31st December 2004Natural product and natural product-derived compounds that
are being evaluated in clinical trials or in registration (current 31 December 2004) have …

Alzheimer's disease (AD) is a genetically complex, progressive and irreversible
neurodegenerative disorder of the brain which involves multiple associated etiological …

Secondary metabolites of Solanaceae plants, sharing tropane skeleton as a common
structural feature, are sharply divided into two classes: tropine and ecgonine derivatives …

The therapeutic arsenal for the treatment of Alzheimer s disease (AD) remains confined to a
group of four inhibitors of AChE and one NMDA receptor antagonist, which are used to …

In the overall scenario of precision medicine, we propose a novel paper-based lab-on-a-
chip to deliver a cost-effective and easy to use sensing tool for customized administration of …

Due to their very good chemical and proteolytic stability, ability to penetrate cell membranes,
and resemblance to a peptide bond, carbamate derivatives have received much attention in …

Publisher Summary The role of muscarinic receptors is highly complex. The recent
pharmacological evidence with novel compounds, together with data from transgenic mice …

Introduction: Brain is supposed to be the most complicated part of the body which is very far
from the reach of drug moieties. The drug entry in to the brain region depends upon various …